AUTHOR=Granger Bradi B., Rusincovitch Shelley A., Avery Suzanne , Batch Bryan C., Dunham Ashley A., Feinglos Mark N., Kelly Katherine , Pierre-Louis Marjorie , Spratt Susan E., Califf Robert M.
TITLE=Missing signposts on the roadmap to quality: a call to improve medication adherence indicators in data collection for population research
JOURNAL=Frontiers in Pharmacology
VOLUME=4
YEAR=2013
URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2013.00139
DOI=10.3389/fphar.2013.00139
ISSN=1663-9812
ABSTRACT=Purpose: Poor adherence to prescribed medicines is associated with increased rates of poor outcomes, including hospitalization, serious adverse events, and death, and is also associated with increased healthcare costs. However, current approaches to evaluation of medication adherence using real-world electronic health records (EHRs) or claims data may miss critical opportunities for data capture and fall short in modeling and representing the full complexity of the healthcare environment. We sought to explore a framework for understanding and improving data capture for medication adherence in a population-based intervention in four U.S. counties.
Approach: We posited that application of a data model and a process matrix when designing data collection for medication adherence would improve identification of variables and data accessibility, and could support future research on medication-taking behaviors. We then constructed a use case in which data related to medication adherence would be leveraged to support improved healthcare quality, clinical outcomes, and efficiency of healthcare delivery in a population-based intervention for persons with diabetes. Because EHRs in use at participating sites were deemed incapable of supplying the needed data, we applied a taxonomic approach to identify and define variables of interest. We then applied a process matrix methodology, in which we identified key research goals and chose optimal data domains and their respective data elements, to instantiate the resulting data model.
Conclusions: Combining a taxonomic approach with a process matrix methodology may afford significant benefits when designing data collection for clinical and population-based research in the arena of medication adherence. Such an approach can effectively depict complex real-world concepts and domains by “mapping” the relationships between disparate contributors to medication adherence and describing their relative contributions to the shared goals of improved healthcare quality, outcomes, and cost.